ArticleJournal of gastroenterology2010

Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma.

Kazumasa Hiroishi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.